ProCE Banner Activity


Optimizing HIV Outcomes in Challenging Scenarios—A Nursing Perspective


Hear from expert nursing faculty as they discuss challenging scenarios in HIV care, including the latest data on individualized ART for people with HIV with multiclass drug resistance and best practices in the evidence-based management of ART for patients with extensive treatment history, comorbidities, drug‒drug interactions, and suboptimal immune response.

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacology credit 

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: February 24, 2023

Expiration: February 23, 2024

No longer available for credit.



Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Jeffrey Kwong


Professor, Division of Advanced Nursing Practice
Rutgers, The State University of New Jersey
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Milena Murray

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Brenice Duroseau

Brenice Duroseau, MSN, FNP-C, RNC-OB, AAHIVS, PhD (C)

Nurse Practitioner
Scientific and Medical Consultant
Johns Hopkins School of Nursing
The Center for Infectious Disease and Nursing Innovation (CIDNI)
Baltimore, Maryland

Robin Hardwicke

Robin Hardwicke, PhD, FNP-C, AACRN, FAAN

General Internal Medicine & Obsterics/Gynecology
McGovern Medical School- The University of Texas Health Science Center Houston
Nurse Practitioner
General Internal Medicine 
UT Physicians 
Houston, Texas 

Provided by

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

ProCE Banner
ProCE Banner


Supported by an educational grant from

ViiV Healthcare

Target Audience

This program is intended for registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Program Learning Goal

The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate the latest data on ARV treatment into the individualized care of persons with HIV to overcome virologic failure with multiclass drug resistance

  • Implement best practices in the evidence-based management of ART for patients with extensive treatment history, comorbidities and/or drug‒drug interactions, and/or suboptimal immune response


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Merck, ViiV; researcher: Gilead Sciences, Janssen, ViiV.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS, has no relevant financial relationships to report.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP: consultant: Gilead Sciences, Janssen, Merck, Theratechnologies, ViiV.

Brenice Duroseau, MSN, FNP-C, RNC-OB, AAHIVS, has no relevant financial relationships to disclose.

Robin Hardwicke, PhD, FNP-C: consultant/advisor/speaker: Gilead Sciences, Napo, Thera.

The planners and content peer reviewers from Clinical Care Options, LLC and the Association of Nurses in AIDS Care (ANAC) do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.00 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from February 24, 2023, through February 23, 2024:    

  1. Create an account or Login at
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities


The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. 

Nursing Continuing Professional Development
Upon full participation in this webinar and completion of an evaluation, participants will be awarded 1.0 nursing contact hour, including 1.0 hour of pharmacotherapeutics content.

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Continuing Pharmacy Education
CCO designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-9999-23-062-H02-P

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.